0000939767-19-000164.txt : 20190819
0000939767-19-000164.hdr.sgml : 20190819
20190819201812
ACCESSION NUMBER: 0000939767-19-000164
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190816
FILED AS OF DATE: 20190819
DATE AS OF CHANGE: 20190819
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: POSTE GEORGE
CENTRAL INDEX KEY: 0001180770
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 191037695
MAIL ADDRESS:
STREET 1: 515 GALVESTON DR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0103
BUSINESS ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
4
1
wf-form4_156626027625737.xml
FORM 4
X0306
4
2019-08-16
0
0000939767
EXELIXIS, INC.
EXEL
0001180770
POSTE GEORGE
C/O EXELIXIS, INC.
1851 HARBOR BAY PARKWAY
ALAMEDA
CA
94502
1
0
0
0
Common Stock
2019-08-16
4
M
0
25000
4.58
A
137792
D
Common Stock
2019-08-16
4
S
0
25000
20.50
D
112792
D
Option (right to buy)
4.58
2019-08-16
4
M
0
25000
0
D
2013-05-23
2020-05-22
Common Stock
25000.0
0
D
Includes 10,317 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.50 to $20.51. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
The option, representing the right to purchase a total of 30,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 23, 2013.
/s/ Jennifer Drimmer Rokovich, Attorney in Fact
2019-08-19